RESEARCH-USE BIOSIMILAR ANTIBODY
Nadecnemab
Monoclonal antibody · IgG4
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain.
TARGETGFRA3
YMonoclonal antibody
CATALOGSC-BS-369
CATALOG NUMBERSC-BS-369
MOLECULAR WEIGHTApprox. 144.86 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain.
Nadecnemab is a recombinant research-use antibody directed against GFRA3.